leucine pyridoxine semaglutide Many clinicians pair GLP-1 therapies with LeuSynergy™ to support pathways involved in fat oxidation, insulin sensitivity, mitochondrial function, and metabolic optimization. Because lasting results aren't driven by appetite regulation alone, they depend DietWorks GLP Semaglutide GLP-1 Receptor Agonist Research

From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025

doi: 10.1016/S2213-8587(21)00246-1 21 EdqvistJRawshaniAAdielsMBjorckLLindMSvenssonAMet al

GLP-1 receptor-agonist weight loss reduces fat but also a meaningful proportion of lean muscle mass

Regular intake helps in converting stored fat into energy, making it an excellent addition to your daily routine for sustained vitality and well-being